Merendino Lauren Insider Trades

Insider Trading History

Track insider trading activity for Merendino Lauren. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Apr 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.09M 329,532 shares
$21.53
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $1.3M 60,157 shares
Last Trade
Feb 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$67.4k 5,814 shares
$11.60
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $1.49M 69,375 shares
Last Trade
Feb 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$172k 15,162 shares
$11.35
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $1.42M 65,971 shares
Last Trade
Feb 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$172k 15,162 shares
$11.35
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $2.37M 110,000 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.05M 184,000 shares
$11.16
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $1.09M 50,809 shares
Last Trade
Nov 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$33.2k 3,726 shares
$8.91
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $953k 44,252 shares
Last Trade
Nov 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$92.7k 10,536 shares
$8.80
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $1.17M 54,535 shares
Last Trade
Nov 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$92.7k 10,536 shares
$8.80
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Nov 06, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.59M 510,200 shares
$8.99
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $7.11M 330,200 shares
Last Trade
Nov 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.78M 420,200 shares
$8.99
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $903k 41,931 shares
Last Trade
Aug 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$25.5k 3,766 shares
$6.77
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $984k 45,697 shares
Last Trade
Aug 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$71.1k 10,536 shares
$6.75
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $1.03M 47,939 shares
Last Trade
Aug 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$71.1k 10,536 shares
$6.75
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $842k 39,088 shares
Last Trade
May 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.7k 3,687 shares
$6.16
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $1.11M 51,626 shares
Last Trade
May 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.7k 3,687 shares
$6.16
$21.53
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Chief Commercial Officer
Holding Value $615k 28,552 shares
Last Trade
Feb 26, 2025 Sale
$4.15M 420,200 shares
$9.87
$21.53
Essa Pharma
Essa Pharma EPIX
Director
Holding Value $5.03k 25,000 shares
Last Trade
Mar 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$226k 25,000 shares
$9.04
$0.20
Essa Pharma
Essa Pharma EPIX
Director
Holding Value $0 0 shares
Last Trade
Jun 06, 2023 Sale
$153k 50,000 shares
$3.05
$0.20
Myovant Sciences
Myovant Sciences MYOV
Chief Commercial Officer
Holding Value $3.99M 147,747 shares
Last Trade
Mar 10, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.91M 145,091 shares
$26.98
$26.98
Myovant Sciences
Myovant Sciences MYOV
Chief Commercial Officer
Holding Value $4.57M 169,538 shares
Last Trade
Jan 18, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$54k 2,008 shares
$26.89
$26.98

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up